Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > SBM could double in a heartbeat

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Sep 30, 2024 1:14pm

76 Views

Post# 36247028

RE:RE:SBM could double in a heartbeat

I agree. Just had another view. The interview is nothing short of a disaster. The host shake her head while Howard read his script!

Maybe a third party can step in and represent the company in negotiations.

<< Previous

Bullboard Posts

Next >>

Lithium miner sees stock surge after fresh results unearthed